136 related articles for article (PubMed ID: 8623479)
1. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
Dunn JF; Hatch J; Precht A; Hart M; Li S
Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
[No Abstract] [Full Text] [Related]
2. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.
Klauser R; Zlabinger GJ; Traindl O; Franz M; Watschinger B; Pohanka E; Kudlacek S; Kovarik J
Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284
[No Abstract] [Full Text] [Related]
3. Late acute rejection in renal transplant recipients: response to steroid treatment.
Prieto C; Pulido F; Rodríguez-Paternina E; Algranati C; Bello I; Farias J; G-Millet V
Transplant Proc; 1992 Feb; 24(1):35-6. PubMed ID: 1539312
[No Abstract] [Full Text] [Related]
4. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
5. Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results.
Pomer S; Waldherr R; Möhring K; Kempter F; Wiesel M; Weimer R
Transplant Proc; 1992 Oct; 24(5):1732-3. PubMed ID: 1412815
[No Abstract] [Full Text] [Related]
6. Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
Buturović-Ponikvar J; Kandus A; Malovrh M; Ponikvar R; Kveder R
Transplant Proc; 1992 Oct; 24(5):1921-3. PubMed ID: 1329287
[No Abstract] [Full Text] [Related]
7. Clinical results of quadruple drug immunosuppression in liver transplantation.
Fabregat J; Fradera R; Jaurrieta E; Figueras J; Rafecas A; Rufi G; Casanovas T; Casais L; Gil Vernet S
Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217
[No Abstract] [Full Text] [Related]
8. Triple drug maintenance therapy in renal transplantation.
Pallardó LM; Sánchez J; Hernandez M; Górriz JL; Sánchez P; Beneyto I; Rochera A
Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343
[No Abstract] [Full Text] [Related]
9. [Immunosuppressive therapy].
Nakamura H
Rinsho Byori; 1991 Jul; Suppl 90():102-14. PubMed ID: 1920848
[No Abstract] [Full Text] [Related]
10. Antilymphocyte globulin for the treatment of steroid non-responsive acute renal allograft rejection.
Griffin PJ; Williams GT; Salaman JR
Clin Nephrol; 1984 Feb; 21(2):115-7. PubMed ID: 6373078
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO
Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784
[No Abstract] [Full Text] [Related]
12. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):20-2. PubMed ID: 2964112
[No Abstract] [Full Text] [Related]
13. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.
Kaden J; May G; Müller P; Groth J; Strobelt V; Eger E; Wohlfahrt L
Transplant Proc; 1995 Feb; 27(1):1060-1. PubMed ID: 7878804
[No Abstract] [Full Text] [Related]
15. OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
Sumrani N; Delaney V; Rajpoot D; Tejani A; Butt K; Hong J
Transplant Proc; 1990 Aug; 22(4):1750-2. PubMed ID: 2117797
[No Abstract] [Full Text] [Related]
16. Renal allograft rejection in a patient with the Wiskott-Aldrich syndrome.
Meisels IS; Strom TB; Roy-Chaudhury P; Abrams J; Shapiro ME
Transplantation; 1995 Apr; 59(8):1214-5. PubMed ID: 7732568
[No Abstract] [Full Text] [Related]
17. Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
Soin AS; Rasmussen A; Jamieson NV; Tokat Y; Watson CJ; Friend PJ; Wight DG; Calne RY
Transplant Proc; 1995 Feb; 27(1):1129-30. PubMed ID: 7878821
[No Abstract] [Full Text] [Related]
18. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
[No Abstract] [Full Text] [Related]
19. Evaluation of corticosteroid therapy for acute renal allograft rejection.
Vineyard GC; Fadem SZ; Dmochowski J; Carpenter CB; Wilson RE
Surg Gynecol Obstet; 1974 Feb; 138(2):225-9. PubMed ID: 4589909
[No Abstract] [Full Text] [Related]
20. Minimum steroid requirements in the late post-transplant period.
Turcotte JG; Dickerman RM; Harper ML
Transplant Proc; 1975 Mar; 7(1):83-8. PubMed ID: 1091049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
